Skip to main content
Newsroom

Press Releases and Featured Media

Oculomotor, Vestibular, Reaction Time, and Cognitive Tests as Objective Measures of Neural Deficits in Patients Post COVID-19 Infection

https://www.frontiersin.org/articles/10.3389/fneur.2022.919596/full

Long COVID after breakthrough SARS-CoV-2 infection [Nature Medicine]

https://www.nature.com/articles/s41591-022-01840-0

Cognitive Impact of Severe COVID Equal to 20 Years of Brain Aging [New Atlas]

https://newatlas.com/health-wellbeing/cognitive-impact-severe-covid-equal-20-years-brain-aging/

How Eye Movements Help Doctors See Long COVID Neurological Effects [Observer-Reporter]

https://observer-reporter.com/living/how-eye-movements-help-doctors-see-long-covid-neurological-effects/article_fc8f4bda-8845-11ec-9ce7-c7e71fc0042e.html

Could This New Eye-Tracking Device Become the Peloton For Brain Health? [WellToDo]

https://www.welltodoglobal.com/could-this-new-eye-tracking-device-become-the-peloton-for-brain-health-welltodo/

Consumer Device Launched to Monitor Mental Acuity [MedTech News]

https://www.med-technews.com/news/Medtech-Diagnostics-news/consumer-device-launched-to-monitor-mental-acuity/

Neuro Kinetics Purchased By Neurolign [Smart Business Dealmakers]

https://www.smartbusinessdealmakers.com/articles/topic/neuro-kinetics-purchases-neurolign/

Subscribe to Receive News Alerts

News Alerts Subscription Form
Fill out my online form.

Our Address

Neurolign USA, LLC
128 Gamma Drive
Pittsburgh, PA 15238

Contact Us

info@neurolign.com

Terms of Use
Privacy Policy
Financial Conflict of Interest Policy
© 2024 Neurolign USA LLC

Subscribe to Receive Important News and Updates

Email Alerts
LinkedIn